Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Health and Quality of Life One Year After Discharge From the Intensive Care Unit (ICU) (QoL_ICU)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02671916
Recruitment Status : Terminated (insufficient number of replies by patients)
First Posted : February 2, 2016
Last Update Posted : March 6, 2019
Sponsor:
Information provided by (Responsible Party):
Prof. Dr. med. Cristoph Haberthür, Klinik Hirslanden, Zurich

Brief Summary:
The goal is to capture the Quality of life and survival of patients one year after the stay at ICU. Data will be collected during the stay in the ICU and evaluated. One year after the ICU stay patients will be send a Quality of Life questionnaire they need to fill out and return. All data will be evaluated together.

Condition or disease Intervention/treatment
Critically Ill Behavioral: questionnaire

Detailed Description:
no detailled description necessary

Layout table for study information
Study Type : Observational [Patient Registry]
Actual Enrollment : 55 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 1 Year
Official Title: Health and Quality of Life One Year After Discharge From the ICU: in Time Not Limited Quality Control After Intensive Medical Treatment
Study Start Date : January 2015
Actual Primary Completion Date : December 2018
Actual Study Completion Date : December 2018

Group/Cohort Intervention/treatment
all patients
questionnaire for patients with ICU stay at least 5 days or longer without interruption at the ICU
Behavioral: questionnaire
Investigation on all study patients, no Intervention, no groups




Primary Outcome Measures :
  1. Survival [ Time Frame: 1 year after ICU discharge ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
all patients with conditions that lead to an ICU stay
Criteria

Inclusion Criteria:

  • patients who are at least 5 days or longer without interruption at the ICU

Exclusion Criteria:

  • patients with less than 4 days at the ICU

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02671916


Locations
Layout table for location information
Switzerland
Klinik Hirslanden
Zurich, Kanton Zurich, Switzerland, 8032
Sponsors and Collaborators
Prof. Dr. med. Cristoph Haberthür
Investigators
Layout table for investigator information
Principal Investigator: Christoph Haberthür, MD Klinik Hirslanden, Zurich
Additional Information:

Layout table for additonal information
Responsible Party: Prof. Dr. med. Cristoph Haberthür, Prof. Dr. med., Klinik Hirslanden, Zurich
ClinicalTrials.gov Identifier: NCT02671916    
Other Study ID Numbers: QOL_2015_HIRS
First Posted: February 2, 2016    Key Record Dates
Last Update Posted: March 6, 2019
Last Verified: March 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Keywords provided by Prof. Dr. med. Cristoph Haberthür, Klinik Hirslanden, Zurich:
QoL and Survival one year after ICU stay
Additional relevant MeSH terms:
Layout table for MeSH terms
Critical Illness
Disease Attributes
Pathologic Processes